ZA905725B - Contrast medium composition - Google Patents

Contrast medium composition

Info

Publication number
ZA905725B
ZA905725B ZA905725A ZA905725A ZA905725B ZA 905725 B ZA905725 B ZA 905725B ZA 905725 A ZA905725 A ZA 905725A ZA 905725 A ZA905725 A ZA 905725A ZA 905725 B ZA905725 B ZA 905725B
Authority
ZA
South Africa
Prior art keywords
contrast medium
medium composition
enhancing agent
physiologically tolerable
magnetically responsive
Prior art date
Application number
ZA905725A
Other languages
English (en)
Inventor
Helge Guttorm Gundersen
Guttorm Gundersen Helge
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed As filed Critical Nycomed As
Publication of ZA905725B publication Critical patent/ZA905725B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1887—Agglomerates, clusters, i.e. more than one (super)(para)magnetic microparticle or nanoparticle are aggregated or entrapped in the same maxtrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1803—Semi-solid preparations, e.g. ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Liquid Crystal Substances (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA905725A 1989-07-21 1990-07-20 Contrast medium composition ZA905725B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898916780A GB8916780D0 (en) 1989-07-21 1989-07-21 Compositions

Publications (1)

Publication Number Publication Date
ZA905725B true ZA905725B (en) 1991-04-24

Family

ID=10660459

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA905725A ZA905725B (en) 1989-07-21 1990-07-20 Contrast medium composition

Country Status (16)

Country Link
EP (2) EP0485429A1 (de)
JP (1) JP2962521B2 (de)
AT (1) ATE101047T1 (de)
AU (1) AU640401B2 (de)
CA (1) CA2059279A1 (de)
DE (1) DE69006415T2 (de)
DK (1) DK0409351T3 (de)
ES (1) ES2048958T3 (de)
FI (1) FI98987C (de)
GB (1) GB8916780D0 (de)
HK (1) HK1003562A1 (de)
IE (1) IE65463B1 (de)
NO (1) NO303483B1 (de)
NZ (1) NZ234574A (de)
WO (1) WO1991001148A1 (de)
ZA (1) ZA905725B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
EP0526503B1 (de) * 1990-04-10 1997-06-04 Imarx Pharmaceutical Corp. Polymere und ihre verwendung als kontrastmittel bei der bilderzeugung mit magnetischer resonanz
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5370901A (en) * 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
US5179955A (en) * 1991-02-22 1993-01-19 Molecular Biosystems, Inc. Method of abdominal ultrasound imaging
US5455308A (en) * 1991-08-01 1995-10-03 Dsm N.V. Endless objects from epoxy resin or unsaturated polyester and thermoplastic polymer
JPH06157355A (ja) * 1992-11-13 1994-06-03 Dai Ichi Seiyaku Co Ltd Ｍｒｉ用粒状製剤
FR2703250A1 (fr) * 1993-03-30 1994-10-07 Chicouri Marcel Nouvelles compositions pharmaceutiques à base de bismuth et leur procédé de préparation.
DE4426204C2 (de) * 1993-07-24 2001-05-23 Infai Inst Fuer Biomedizinisch Diagnostikum und seine Verwendung
JP2909876B2 (ja) * 1994-01-24 1999-06-23 恭弘 小川 造影剤
CA2182213A1 (en) * 1994-01-28 1995-08-03 William George Gorman Oral magnetic particle formulation
EP1031354A3 (de) 1999-01-19 2003-02-05 Rohm And Haas Company Polymere MRI Kontrastmittel

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
SE463651B (sv) 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
EP0184899B1 (de) * 1984-11-01 1990-04-18 Nycomed As Paramagnetische Kontrastmittel für die Anwendung in "in vivo" NMR-diagnostischen Methoden und die Herstellung davon
DE3443252A1 (de) 1984-11-23 1986-05-28 Schering AG, 1000 Berlin und 4709 Bergkamen Dextran-magnetit-komplexe fuer die nmr-diagnostik
US4675173A (en) 1985-05-08 1987-06-23 Molecular Biosystems, Inc. Method of magnetic resonance imaging of the liver and spleen
US4729892A (en) * 1986-03-21 1988-03-08 Ciba-Geigy Corporation Use of cross-linked hydrogel materials as image contrast agents in proton nuclear magnetic resonance tomography and tissue phantom kits containing such materials
US4770183A (en) 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
SE8704157L (sv) 1987-10-26 1989-04-27 Carbomatrix Ab C O Ulf Schroed Superparamagnetiska partiklar och foerfarande foer framstaellning daerav samt anvaendning

Also Published As

Publication number Publication date
EP0485429A1 (de) 1992-05-20
JP2962521B2 (ja) 1999-10-12
GB8916780D0 (en) 1989-09-06
NO303483B1 (no) 1998-07-20
AU6147590A (en) 1991-02-22
DE69006415T2 (de) 1994-05-11
IE902658A1 (en) 1991-02-27
FI98987C (fi) 1997-09-25
ES2048958T3 (es) 1994-04-01
WO1991001148A1 (en) 1991-02-07
FI920237A0 (fi) 1992-01-20
JPH04506806A (ja) 1992-11-26
CA2059279A1 (en) 1991-01-22
EP0409351B1 (de) 1994-02-02
FI98987B (fi) 1997-06-13
NZ234574A (en) 1992-11-25
IE65463B1 (en) 1995-11-01
NO920263D0 (no) 1992-01-20
DK0409351T3 (da) 1994-03-07
HK1003562A1 (en) 1998-10-30
DE69006415D1 (de) 1994-03-17
AU640401B2 (en) 1993-08-26
ATE101047T1 (de) 1994-02-15
NO920263L (no) 1992-01-20
EP0409351A1 (de) 1991-01-23

Similar Documents

Publication Publication Date Title
GB9023822D0 (en) Face mask and face mask components
AU2017488A (en) Antifoam agents
EP0500941A4 (en) Novel composite and emulsion composition
IL93922A0 (en) Catadioptric projector,catadioptric projection system and process
EP0363654A3 (de) Prothese
GB2245585B (en) Shampoo composition containing a water-soluble polymer and an anionic surfactant and/or an ampholytic surfactant.
GB8925358D0 (en) Buffer seals
GB8916780D0 (en) Compositions
GB8916782D0 (en) Compositions
GB9005022D0 (en) Pressure checker
GB2255111B (en) Deinking agent
EP0458988A4 (en) Positive resist composition
ZA902666B (en) Filtration medium and face mask containing the same
GB2236813B (en) Non-contact seal
AU567814B2 (en) Colour developer composition and record material carrying the composition
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
GB9008087D0 (en) Opaque projector
HK1000427B (en) Opaque projector
EP0424063A3 (en) Fluorine resin composition
EP0386780A3 (en) Photosensitive composition and polymer therefor
GB8923587D0 (en) Draught sealing device
EP0431815A3 (en) Venting and sealing mechanism
GB8908915D0 (en) Tamperproof seal
AU107003S (en) Face mask
AU8146887A (en) N (halobenzoyl)n'(4-cf3-f-phenyl)- ureas & - thioureas